Growth Metrics

Boston Scientific (BSX) Work In Process (2016 - 2025)

Boston Scientific (BSX) has disclosed Work In Process for 17 consecutive years, with $246.0 million as the latest value for Q4 2025.

  • Quarterly Work In Process rose 27.46% to $246.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $246.0 million through Dec 2025, up 27.46% year-over-year, with the annual reading at $246.0 million for FY2025, 27.46% up from the prior year.
  • Work In Process hit $246.0 million in Q4 2025 for Boston Scientific, roughly flat from $245.0 million in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $246.0 million in Q4 2025 to a low of $120.0 million in Q1 2021.
  • Historically, Work In Process has averaged $175.2 million across 5 years, with a median of $175.5 million in 2023.
  • Biggest five-year swings in Work In Process: plummeted 34.78% in 2021 and later grew 27.46% in 2025.
  • Year by year, Work In Process stood at $128.0 million in 2021, then increased by 14.84% to $147.0 million in 2022, then rose by 18.37% to $174.0 million in 2023, then rose by 10.92% to $193.0 million in 2024, then increased by 27.46% to $246.0 million in 2025.
  • Business Quant data shows Work In Process for BSX at $246.0 million in Q4 2025, $245.0 million in Q3 2025, and $218.0 million in Q2 2025.